PHASE-II EVALUATION OF THE SULFONYLUREA LY186,641 IN MEN WITH HORMONE-INDEPENDENT METASTATIC PROSTATE-CANCER

被引：1
|
作者：
WILDING, G
GRINDEY, G
MUNSHI, N
SEITZ, D
EINHORN, L
机构：
[1] WM S MIDDLETON VA HOSP,MADISON,WI
[2] ELI LILLY CORP,LILLY RES LABS,INDIANAPOLIS,IN
[3] INDIANA UNIV,MED CTR,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN 46204
来源：
INVESTIGATIONAL NEW DRUGS | 1993年 / 11卷 / 2-3期
关键词：
D O I：
10.1007/BF00874156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [41] PHASE-II EVALUATION OF AMSA IN PATIENTS WITH METASTATIC LUNG-CANCER
    NICHOLS, WC
    EAGAN, RT
    FRYTAK, S
    INGLE, JN
    CREAGAN, ET
    KVOLS, LK
    CANCER TREATMENT REPORTS, 1980, 64 (12): : 1383 - 1385
  • [42] PHASE-II EVALUATION OF TRIAZINATE IN PATIENTS WITH METASTATIC LUNG-CANCER
    CREAGAN, ET
    EAGAN, RT
    FLEMING, TR
    FRYTAK, S
    INGLE, JN
    KVOLS, LK
    NICHOLS, WC
    CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1057 - 1059
  • [43] Phase-II study of pomegranate juice for men with prostate cancer and increasing PSA
    Pantuck A.J.
    Zomorodian N.
    Belldegrun A.S.
    Current Urology Reports, 2006, 7 (1) : 7 - A1
  • [44] Translationally regulated C/EBPβ isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells
    Kim, Myoung H.
    Field, Jerrel
    PROSTATE, 2008, 68 (12): : 1362 - 1371
  • [45] Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
    Paul, Devchand
    Vukelja, Svetislava J.
    Holmes, Frankie Ann
    Blum, Joanne L.
    McIntyre, Kristi J.
    Lindquist, Deborah L.
    Osborne, Cynthia R.
    Sanchez, Ines J.
    Goldschmidt, Jerome H.
    Wang, Yunfei
    Asmar, Lina
    Strauss, Lewis
    O'Shaughnessy, Joyce
    NPJ BREAST CANCER, 2019, 5 (1)
  • [46] Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
    Devchand Paul
    Svetislava J. Vukelja
    Frankie Ann Holmes
    Joanne L. Blum
    Kristi J. McIntyre
    Deborah L. Lindquist
    Cynthia R. Osborne
    Ines J. Sanchez
    Jerome H. Goldschmidt
    Yunfei Wang
    Lina Asmar
    Lewis Strauss
    Joyce O’Shaughnessy
    npj Breast Cancer, 5
  • [47] A PHASE-II STUDY OF KETOCONAZOLE COMBINED WITH WEEKLY DOXORUBICIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER RESULTS IN A HIGH RESPONSE RATE
    SELLA, A
    AMATO, R
    ELLERHORST, J
    KILBOURN, R
    BUI, C
    LOGOTHETIS, C
    ZUKIWSKI, A
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 717 - 718
  • [48] A phase I/II study of docetaxel and atrasentan in men with metastatic hormone-refractory prostate cancer (HRPC)
    George, DJ
    Gockerman, JP
    Petros, W
    Haley, S
    Franklin, AD
    Creel, PA
    Turner, AG
    Sleep, D
    Hurwitz, HI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 419S - 419S
  • [49] A PHASE-II STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER - AN ILLINOIS CANCER CENTER STUDY
    KUZEL, TM
    TALLMAN, MS
    SHEVRIN, D
    BRAUD, E
    KILTON, L
    JOHNSON, P
    KOZLOWSKI, J
    VOGELZANG, NJ
    BLOUGH, R
    BENSON, AB
    CANCER, 1993, 72 (06) : 1965 - 1968
  • [50] A PHASE-II STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER - AN ILLINOIS CANCER CENTER STUDY
    LOKICH, J
    CANCER, 1994, 73 (05) : 1536 - 1537
12345